Engerix-B (GlaxoSmithKline) 72 hr Manufacturer Immune globulin (human) Gamastan S/D (Bayer) Cumulative exposure for 7 days Manufacturer Influenza virus vaccine Fluarix (GlaxoSmithKline ...

Malaysia’s health ministry said there is no rising trend of influenza cases in Malaysia. Read more at straitstimes.com.

The shortage of certain types of influenza vaccines could end as early as next month with the arrival of new stock, says ...

KUALA LUMPUR, Feb 9 — Health Minister Datuk Seri Dzulkefly Ahmad said there was no cause for worry over the shortage of ...

There is no need to panic as the Health Ministry has an adequate supply of flu vaccines in its healthcare facilities, says ...

GlaxoSmithKline Pharmaceuticals Limited is ... In September 2020, the Company launched tetravalent influenza flu vaccine, Fluarix Tetra to help combat influenza.In June, 2021 Company launched ...

A second group of adults aged 50 to 64 received mRNA-1083 or GSK’s influenza vaccine Fluarix, once again given alongside Spikevax. mRNA-1083 consists of components of mRNA-1010, Moderna’s ...

Health Minister Datuk Seri Dzulkefly Ahmad said there was no cause for worry over the shortage of certain flu vaccines, explaining ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...